Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Dashboard
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Analytics
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Articles
More+
Staffing
Media Kit
Membership Levels
By The Numbers
Investment
103 Articles Available
1
5
Can't find what you're looking for? Try our
advanced search
.
Investment
Gencove Raises $3M Investment Led by Spero Ventures to Expand Genome Sequencing Platform
PR-M03-19-NI-045
Finance
Lilly Announces Final Results of Elanco Exchange Offer
PR-M03-19-NI-046
Microbiome
The Global Human Microbiome Market is Expected to Reach US$ 1,197.08 Mn in 2025 from US$ 257.30 Mn in 2017
PR-M03-19-NI-041
Investment
Successful Funding Round Could Lead to Commercialization of Bio-integrative Bone Pin
PAO-M03-19-NI-023
Investment in Innovation
How Agile Investment Drives Innovation
PAP-Q1-2019-CL-004
Form-Fill-Seal
Investing in Form-Fill-Seal Technology
PAP-Q1-2019-CL-011
Virtual Panel
Reprioritizing to Bring FY2020 into Focus
PAP-Q1-2019-CL-032
Benefitting U.S. Clients
Rentschler Biopharma SE Sets Foot in the U.S. to Strengthen its World-Class CDMO Position
PAP-Q1-2019-CL-033
Attracting Investment
Preparing Middle-Market Firms to Attract Investment
PAP-Q1-2019-CL-007
Meet the Investor
Selecting the Right Private Equity Partner to Build a Leading Outsourcing Provider
PAP-Q1-2019-CL-024
Q of E
Quality of Earnings: The Most Important Term You Probably Don’t Know
PAP-Q1-2019-CL-022
Consolidation
Factors Driving Consolidation in the CDMO Space
PAP-Q1-2019-CL-023
Leveraging Expertise
Similar, Different and Constantly Varied
PAP-Q1-2019-CL-021
Generics
Finding the Right Product Platform: A Personal Perspective
PAP-Q1-2019-CL-034
Global Partner
A World-Class Partner for Today’s Market
PAP-Q1-2019-CL-039
Fill/Finish
Fill/Finish: Increasing Investment and Flexibility for Effective Manufacturing
PAP-Q1-2019-CL-029
M&A
Big Deals Already Begun for Biotechs in 2019
PAO-M03-19-NI-011
Funding
Human API Announces New Investors, $10M in Funding, to Grow Consumer Health Data Network
PR-M02-19-NI-027
Investment
KenSci Raises $22 Million in Series B Funding to Fuel Growth
PR-M02-19-NI-021
Investment
3M Board Increases Dividend 6 Percent
PR-M02-19-NI-015
Investment
Embleema Closes $3.7M Series A Funding Round and Joins Techstars Alchemist Blockchain Accelerator Program
PR-M02-19-NI-013
Oncology
Trovagene and PoC Capital Enter Agreement to Fund Clinical Development of Onvansertib in Metastatic Colorectal Cancer (mCRC)
PR-M01-19-NI-089
Funding
Company Developing Tech to Identify Allosteric Mutations Raises Big Funds
PAO-M01-19-NI-019
Investment
Computational Drug Discovery Company Confirms Investment
PAO-M01-19-NI-015
1
5
»
